Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.59 |
| ▸ | TSHR | P16473 | 2/20 | 0.51 |
| ▸ | NPC1 | O15118 | 4/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | ADRA2A | P08913 | 3/20 | 0.44 |
| ▸ | ADRA2B | P18089 | 3/20 | 0.44 |
| ▸ | ADRA2C | P18825 | 3/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 3/20 | 0.40 |
| ▸ | GLS | O94925 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | DRD2 | P14416 | 1/20 | 0.38 |
| ▸ | DRD3 | P35462 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8104697 | 0.98 | TAAR1 (0.57) | TAAR1TSHRNPC1SMN1; SMN2ALDH1A1 | |
| SCHEMBL3609572 | 0.98 | TAAR1 (0.57) | TAAR1TSHRNPC1SMN1; SMN2ALDH1A1 | |
| SCHEMBL8100975 | 0.98 | TAAR1 (0.57) | TAAR1TSHRNPC1SMN1; SMN2ALDH1A1 | |
| SCHEMBL4847564 | 0.98 | TAAR1 (0.57) | TAAR1TSHRNPC1SMN1; SMN2ALDH1A1 | |
| SCHEMBL8091833 | 0.98 | TAAR1 (0.57) | TAAR1TSHRNPC1SMN1; SMN2ALDH1A1 | |
| SCHEMBL8105148 | 0.98 | TAAR1 (0.57) | TAAR1TSHRNPC1SMN1; SMN2ALDH1A1 | |
| SCHEMBL4841431 | 0.98 | TAAR1 (0.57) | TAAR1TSHRNPC1SMN1; SMN2ALDH1A1 | |
| SCHEMBL3465372 | 0.98 | TAAR1 (0.57) | TAAR1TSHRNPC1SMN1; SMN2ALDH1A1 | |
| SCHEMBL9670131 | 0.96 | TAAR1 (0.55) | TAAR1TSHRNPC1SMN1; SMN2ALDH1A1 | |
| SCHEMBL11461413 | 0.96 | TAAR1 (0.55) | TAAR1TSHRNPC1SMN1; SMN2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119504798-A | Oligomer and organic electronic device comprising same | 广州追光科技有限公司 | 2025-02-25 | — | — | CN | disclosed |
| CN-114605619-B | Organic photovoltaic device active layer material containing star-structure flexible chain segments, and preparation and application thereof | 华南理工大学 | 2023-12-29 | — | — | CN | disclosed |
| CN-114605619-A | Active layer material of organic photovoltaic device containing star-structure flexible chain segment and preparation and application thereof | 华南理工大学 | 2022-06-10 | — | — | CN | disclosed |
| US-9006469-B2 | Luminescence quenching compounds | ANASPEC INCORPORATED (US) | 2015-04-14 | — | — | US | disclosed |
| US-9006469-B2 | Luminescence quenching compounds | ANASPEC INCORPORATED (US) | 2015-04-14 | — | — | US | disclosed |
| US-9006469-B2 | Luminescence quenching compounds | ANASPEC INCORPORATED (US) | 2015-04-14 | — | — | US | disclosed |
| US-20140031524-A1 | Luminescence quenching compounds | ANASPEC INCORPORATED (US) | 2014-01-30 | — | — | US | disclosed |
| US-20140031524-A1 | Luminescence quenching compounds | ANASPEC INCORPORATED (US) | 2014-01-30 | — | — | US | disclosed |
| US-20140031524-A1 | Luminescence quenching compounds | ANASPEC INCORPORATED (US) | 2014-01-30 | — | — | US | disclosed |
| US-8503167-B2 | Solid electrolytic capacitor and manufacturing method thereof | SANYO ELECTRIC CO., LTD. (JP) | 2013-08-06 | — | — | US | disclosed |
| US-20100193745-A1 | CONDUCTIVE POLYMER FILM, CONDUCTIVE POLYMERIC MATERIAL AND ELECTRONIC DEVICE | SANYO ELECTRIC CO., LTD. (JP) | 2010-08-05 | — | — | US | disclosed |
| US-20060223076-A1 | Cyanine dyes and their applications as luminescence quenching compounds | ANASPEC, INC. (US) | 2006-10-05 | — | — | US | disclosed |
| US-6166003-A | Heterocyclic compounds for cancer chemoprevention | LKT LABORATORIES, INC. (US) | 2000-12-26 | — | — | US | disclosed |
| WO-2000049013-A1 | ISOTHIO CYANATO ALKYLTHIOPHENES AS CANCER CHEMOPROTECTIVE AGENTS | LKT LABORATORIES, INC. (US) | 2000-08-24 | — | — | WO | disclosed |
| EP-0292840-B1 | Cyclic amine derivatives, medicaments containing these compounds and procedure for their preparation | THOMAE GMBH DR K (DE) | 1995-08-09 | — | — | EP | disclosed |
| US-5175157-A | Cardiovascular disorders | BOEHRINGER INGELHEIM GMBH (DE) | 1992-12-29 | — | — | US | disclosed |
| US-5116986-A | HETEROAROMATIC AMINE DERIVATIVES | DR. KARL THOMAE GMBH (DE) | 1992-05-26 | — | — | US | disclosed |
| US-4912115-A | Cardiovascular disorders | DR. KARL THOMAE GMBH (DE) | 1990-03-27 | — | — | US | disclosed |
| EP-0269968-A2 | Heteroaromatic amine derivatives, medicaments containing them and process for their preparation | Dr. Karl Thomae GmbH (DE) | 1988-06-08 | — | — | EP | disclosed |
| US-4239769-A | ANTISECRETORY AGENT; GASTRIC JUICE | ALLEN & HANBURYS LIMITED (GB) | 1980-12-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060223076-A1 | Cyanine dyes and their applications as luminescence quenching compounds | TYR, ABCG2, CYBA | TAAR1 1683/4885TSHR 3003/4885NPC1 909/4885 |
| US-20140031524-A1 | Luminescence quenching compounds | ABCG2, TYR, GFPT1 | TAAR1 2366/4885TSHR 3047/4885NPC1 1147/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.